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Abstract
Protein arrays are fast becoming established as a means to monitor protein expression
levels and investigate protein interactions and function. They present particular technical
demands that will need to be solved in order to achieve the maximum capability of efﬁcient
and sensitive protein analysis in the high throughput setting of functional genomics. The
following resume ´ of some major issues around this new technology was made as the
chairperson’s introduction to the workshop session on peptide and protein chips. Copyright
# 2001 John Wiley & Sons, Ltd.
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Array formats are well established for global
analysis of nucleic acids, as in the use of oligo-
nucleotide and cDNA arrays for gene expression
proﬁling. In relation to protein expression, how-
ever, information from DNA arrays leaves much to
be desired. They provide a relatively inaccurate
guide to the ﬁnal concentrations of gene products
within the cell, since it is now accepted that mRNA
levels do not equate with protein concentrations
[1], and they reveal nothing at all about post-
translational modiﬁcations and protein-protein
interactions. For information about the expression
of the proteome, protein and peptide arrays are
becoming major tools and the information that will
be obtained from them in the future will comple-
ment that from DNA arrays (some recent reviews
are listed at the end of this article).
The technology of protein arrays is in many
respects an extension of well established methods,
such as ELISA and dot blotting, with the new gloss
that high throughput detection systems enable the
user to investigate thousands of proteins in parallel.
One goal, therefore, is to create protein arrays
that contain very large sets of proteins and, at the
limit, entire proteomes. Protein arrays are also
ﬂagged as being the next stage for proteomics.
Two-dimensional gel electrophoresis technology, on
which most proteome proﬁling is based [2], is
limited in various ways (it is technically demanding,
has problems ﬁnding proteins present in really low
amounts, etc.) and could not be used as a practical
diagnostic method. A protein ‘chip’ could sensi-
tively detect low levels of proteins with minimal
technical know-how on the part of the user and be
used to measure protein or analyte concentrations
in plasma or tissues.
At least three areas for the application of protein
arrays can be highlighted, each of which will require
different formats and readout methods. They can be
summarised as: ﬁnding what is present in a protein
mixture, such as a tissue extract, and making
quantitative comparisons between samples; selecting
individual members from libraries of phenotype-
genotype linkages for further expression or manip-
ulation; and discovering new functions for proteins,
including their interactions, in order to understand
the workings of the living cell.
First, there is the detection of proteins in cells and
tissue extracts, with application in expression proﬁl-
ing and proteome analysis. A major format will be
arrays of immobilised antibodies [3] or ligand-binding
scaffolds [4] which will be used to detect quantitative
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eased tissues, providing complementary information
to mRNA proﬁling using DNA chips. For differ-
ential display, the antibody array could be probed
with ﬂuorescently labelled proteins from two differ-
ent cell states, in which cell lysates are labelled with
different ﬂuorophores and mixed such that the
colour acts as a readout for the change in
abundance [3]. Antigen arrays will ﬁnd diagnostic
applications for detecting antibodies in serum as a
screen for infections and autoimmunity.
Secondly, as a two-dimensional display of indivi-
dual elements, a protein array can be used to screen
phage or ribosome display libraries, in order to
select speciﬁc binding partners, including antibodies
[5], synthetic scaffolds, peptides and aptamers. In
this way, ‘library against library’ screening can be
carried out, with one library distributed as the
immobilised elements of the array and the other
being a mixture of protein-gene elements in suspen-
sion to which the array is exposed. Drug screening
against an array of protein targets identiﬁed from
genome projects is another possible use.
Thirdly, the biochemical functions of arrayed
proteins, such as enzyme activities [6] or inter-
actions with other proteins, DNA, etc. [7], can be
tested in parallel. For detecting interactions, protein
arrays could be in vitro alternatives to the cell-
based yeast two-hybrid system and useful where the
latter is deﬁcient, such as those interactions invol-
ving secreted proteins, proteins with disulphide
bridges and membrane-bound proteins.
There are several important technical challenges
and bottlenecks in protein array technologies, some
of which are unique to proteins while others are
common to high throughput methods in general.
They include the problems of obtaining global
protein expression for array construction, chemical
aspects of protein coupling to surfaces, the sensiti-
vity of detection systems, and matters of standard-
isation and data storage. The issues which need to
be addressed include the following:
(i) The limiting step in creating protein arrays,
especially those which aim to be global, is the
production of the huge diversity of proteins
which will form the array elements. Methods
available include puriﬁcation from natural
sources [7], cell-based expression systems for
recombinant proteins [8], production in vitro by
cell-free translation systems [9], and synthetic
methods (for peptides) [10]. The problem is
how to make any of these sufﬁciently com-
prehensive such that potentially all proteins
become available; expression systems will have
to be improved and different systems may
have to be used for different proteins.
(ii) Proteins are complicated by the existence of
frequent and varied post-translational modiﬁ-
cations (PTMs), which increase the number of
possible proteins at least 10-fold over the
number of genes. The problem will be how to
incorporate PTMs into protein arrays.
(iii) Ideally, arrayed proteins should be correctly
folded and functional. How can this be ensured
and validated?
(iv) How will membrane proteins, which are often
functional only in a lipid environment, be
arrayed and interrogated on a chip surface?
(v) What are the best coupling chemistries and
supports? There are several options available
in both categories. For example, support sur-
faces may be chemically derivatised glass
slides [11], agarose ﬁlms on glass [12], gel pads
[13], microwells [14], nitrocellulose [7] or
PVDF membranes [8]. What are their relative
merits and what is the stability and lifetime of
protein arrays in different formats?
(vi) Detection methods are another important con-
sideration, with requirements of sensitivity,
accuracy and quantitation over a wide range.
Current options include ﬂuorescence [3], mass
spectrometry, and DNA ampliﬁcation (PCR,
rolling circle) [15]. The design of the array
will be inﬂuenced by the readout system.
(vii) Standardisation is an issue which is common
to high throughput technologies: the existence
and development of many alternative formats
and conditions inevitably leads to problems in
comparison of results. Standards for protein
arrays and a framework for their implementa-
tion will need to be established at an interna-
tional level.
(viii) Data management and databases: how will
protein array data be stored, annotated and
accessed?
(ix) How will protein interactions detected on chips
be interpreted and validated in terms of func-
tional intracellular networks?
(x) Last, but not least: what will be the unit costs
of any of the methodologies on offer? Will it
be economically feasible to produce proteome
chips on the scale of DNA chips?
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